معرفی
Torbjørn Omland is a Professor at the University of Oslo, affiliated with the Division of Medicine and Laboratory Sciences, and based at Akershus University Hospital. His primary research focuses on cardiovascular biomarkers and their clinical applications. He maintains active clinical research collaborations and leads studies on cardiac risk stratification.
Research Focus: Dr. Omland specializes in cardiovascular biomarker research with particular emphasis on:
- Cardiac troponins for myocardial injury detection
- Secretoneurin in arrhythmia prediction
- Biomarker-guided heart failure management
- Sex-specific differences in cardiovascular biomarkers
- Cardio-oncology interfaces
- Post-COVID cardiac complications
- Population-based cardiovascular risk assessment
Research Trends: Analysis of Dr. Omland's recent publications reveals consistent focus on:
- Validation of novel biomarker assays and algorithms
- Long-term prognostic studies in diverse populations
- Cardiac implications of non-cardiac conditions (renal failure, cancer, COVID-19)
- Sex-specific analysis of cardiovascular risk
- Integration of imaging with biomarker data
- Implementation of clinical guidelines in real-world settings
Laboratory & Collaborations: Dr. Omland collaborates extensively through the Cardiovascular Research Group (CRG) and participates in multinational consortia including the Akershus Cardiac Examination studies and HUNT research initiative. His team focuses on translational research bridging laboratory medicine and clinical cardiology.
